CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Wellbeing Digital Sciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Wellbeing Digital Sciences Inc
275 Dundas Street,, Unit A1605
Phone: (604) 687-2038p:604 687-2038 LONDON, ON  N6B 3L1  Canada Ticker: KONEFKONEF
Business Summary
Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company. The Company is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. It operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. It operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. It is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
7/31/20227/31/2021Yes----

Industries
SIC Code Description
8049 Offices and clinics of health practitioners, not elsewhere classified
8093 Specialty outpatient facilities, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director NajlaGuthrie 3/7/2022 6/1/2021
Chief Financial Officer TerryZimaro 6/15/2022 6/15/2022
Independent Director BrendanPurdy 1/7/2020 1/7/2020
Independent Director NatashaRaey 9/18/2020 9/18/2020
Independent Director MohammadSharifi 11/22/2022 11/22/2022

Subsidiaries
Business Name Address City State/Province Country
KGK Science Inc. 255 Queens Ave. London ON Canada
Mindscape Ketamine & Infusion Therapy Pllc 2211 Norfolk St Houston TX United States

Business Names
Business Name
Integrated Rehab and Performance Ltd.
KGK Science Inc.
KONEF
Mindscape Ketamine & Infusion Therapy Pllc

General Information
Outstanding Shares: 129,971,885 (As of 7/31/2022)
Stock Exchange: OTC
Fax Number: (604) 351-6647
Email Address: partnerships@wellbeingdigital.co


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 14, 2024